Interestingly, novel JAK2/STAT3 inhibitor, WP1066, can penetrate the blood-brain-barrier, suppress brain metastases in vivo, and prolong overall survival in mice inoculated with brain-trophic TNBC breast cancer cells via an intracardiac injection. Here, STAT3 is linked to breast cancer.